Stock ScreenerStock IdeasStrong Buys According to Wall StreetStrong Buys According to Wall StreetCompanies with high upside and a consensus strong buy recommendation from Wall Street analysts
Stock ScreenerStock IdeasStrong Buys According to Wall Street
Consensus: Strong Buy
Analysts: >= 3
Upside/Downside: Large Upside
| Ticker | Company | Zen Rating | Financials | Market Cap | ROE | ROA | ROCE | ROIC | D/E | Current Ratio | Gross Margin | Profit Margin | Operating Margin |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XOMA | XOMA ROYALTY CORP | $312.30M | 20.30% | 7.20% | 10.39% | 12.10% | 1.77 | 3.91 | 100.00% | 35.20% | 51.78% | ||
| AKA | AKA BRANDS HOLDING CORP | $126.08M | -23.20% | -6.60% | -3.72% | -3.40% | 2.74 | 1.35 | 57.40% | -4.40% | -1.90% | ||
| DMAC | DIAMEDICA THERAPEUTICS INC | $489.01M | -83.30% | -73.60% | -61.70% | -90.10% | 0.11 | 10.67 | N/A | N/A | N/A | ||
| NTGR | NETGEAR INC | $697.86M | -5.00% | -3.20% | -4.49% | -8.50% | 0.60 | 2.85 | 36.00% | -3.70% | -3.67% | ||
| CHYM | CHIME FINANCIAL INC | $9.81B | N/A | N/A | N/A | N/A | 0.36 | 4.94 | N/A | N/A | N/A | ||
| ENTA | ENANTA PHARMACEUTICALS INC | $425.15M | -93.80% | -26.10% | -32.68% | -28.20% | 3.34 | 4.21 | 100.00% | -125.40% | -116.14% | ||
| CGTX | COGNITION THERAPEUTICS INC | $149.18M | -150.10% | -95.90% | -76.14% | 728.50% | 0.19 | 6.45 | N/A | N/A | N/A | ||
| OTLY | OATLY GROUP AB | $351.07M | -265.00% | -28.30% | -52.70% | -16.50% | 40.65 | 0.42 | 30.60% | -26.70% | -10.58% | ||
| CRVO | CERVOMED INC | $78.19M | -76.80% | -68.10% | -98.36% | -106.60% | 0.18 | 6.66 | 100.00% | -415.40% | -415.36% | ||
| RZLT | REZOLUTE INC | $166.91M | -62.80% | -57.10% | -51.99% | -81.70% | 0.08 | 15.15 | N/A | N/A | N/A | ||
| BSVN | BANK7 CORP | $416.80M | 19.10% | 2.40% | N/A | 3.70% | 6.82 | N/A | 100.00% | 45.30% | 59.90% | ||
| KYMR | KYMERA THERAPEUTICS INC | $6.45B | -33.40% | -28.60% | -28.61% | -33.60% | 0.17 | 7.38 | 100.00% | -674.80% | -674.04% | ||
| PHR | PHREESIA INC | $979.66M | -1.80% | -1.30% | -1.16% | -6.20% | 0.32 | 2.44 | 68.20% | -1.20% | -0.81% | ||
| SMWB | SIMILARWEB LTD | $645.40M | -123.40% | -12.70% | -31.95% | -940.40% | 8.93 | 0.75 | 78.90% | -11.20% | -7.73% | ||
| CYBN | CYBIN INC | $153.86M | -51.80% | -44.00% | -59.24% | -307.40% | 0.30 | 8.58 | N/A | N/A | N/A | ||
| ICHR | ICHOR HOLDINGS LTD | $612.73M | -5.90% | -4.10% | -3.42% | -5.30% | 0.43 | 3.08 | 9.80% | -4.30% | -2.96% | ||
| PRQR | PROQR THERAPEUTICS NV | $250.97M | -58.40% | -29.30% | -44.87% | -9,969.30% | 1.18 | 3.36 | 100.00% | -264.80% | -254.60% | ||
| TBPH | THERAVANCE BIOPHARMA INC | $920.72M | 14.70% | 7.60% | 13.16% | 20.60% | 0.79 | 9.48 | 100.00% | 36.50% | 61.95% | ||
| SGMT | SAGIMET BIOSCIENCES INC | $202.61M | -42.40% | -40.30% | -48.36% | -70.10% | 0.08 | 13.06 | N/A | N/A | N/A | ||
| ELVN | ENLIVEN THERAPEUTICS INC | $1.00B | -24.90% | -24.00% | -20.41% | -34.80% | 0.03 | 32.95 | N/A | N/A | N/A | ||
| CTNM | CONTINEUM THERAPEUTICS INC | $339.39M | -32.30% | -30.30% | -32.19% | -35.60% | 0.06 | 29.07 | N/A | N/A | N/A | ||
| XNCR | XENCOR INC | $1.18B | -20.40% | -14.50% | -12.25% | -9.80% | 0.39 | 6.00 | 100.00% | -87.10% | -63.85% | ||
| PSN | PARSONS CORP | $6.74B | 15.60% | 6.90% | 13.39% | 23.10% | 1.20 | 1.67 | 22.00% | 6.00% | 8.56% | ||
| ATR | APTARGROUP INC | $7.97B | 16.00% | 8.90% | 15.64% | 22.00% | 0.84 | 1.19 | 38.10% | 11.50% | 15.38% | ||
| SYRE | SPYRE THERAPEUTICS INC | $2.61B | -31.20% | -26.80% | -32.51% | -35.40% | 0.11 | 10.91 | N/A | N/A | N/A | ||
| ORIC | ORIC PHARMACEUTICALS INC | $913.51M | -45.30% | -41.80% | -32.91% | -55.20% | 0.06 | 14.65 | N/A | N/A | N/A | ||
| FBRX | FORTE BIOSCIENCES INC | $267.70M | -75.60% | -65.90% | -61.53% | -3,473.20% | 0.15 | 7.34 | N/A | N/A | N/A | ||
| PVLA | PALVELLA THERAPEUTICS INC | $1.17B | -68.50% | -45.50% | -49.43% | 433.60% | 0.73 | 6.49 | 100.00% | 66,162.30% | 52,807.55% | ||
| RIOT | RIOT PLATFORMS INC | $5.69B | 5.10% | 4.00% | 5.02% | 5.10% | 0.28 | 1.47 | 50.60% | 25.70% | 32.44% | ||
| IBIO | IBIO INC | $43.63M | -83.60% | -62.80% | -34.28% | -171.80% | 0.15 | 8.40 | 100.00% | -4,021.60% | -3,983.40% | ||
| TNGX | TANGO THERAPEUTICS INC | $1.26B | -60.80% | -38.70% | -52.38% | -48.80% | 0.31 | 8.88 | 100.00% | -151.10% | -150.99% | ||
| TVRD | TVARDI THERAPEUTICS INC | $41.37M | -115.90% | -33.70% | -31.65% | -30.90% | 0.40 | 3.48 | 100.00% | -346.50% | -220.05% | ||
| IDYA | IDEAYA BIOSCIENCES INC | $2.98B | -15.50% | -14.40% | -14.34% | -17.40% | 0.09 | 12.44 | 100.00% | -74.80% | -74.82% | ||
| BITF | BITFARMS LTD | $1.54B | -20.50% | -17.00% | -22.19% | -22.80% | 0.31 | 3.20 | -2.80% | -48.30% | -56.22% | ||
| NAVN | NAVAN INC | N/A | N/A | N/A | N/A | N/A | -0.86 | 2.88 | N/A | N/A | N/A | ||
| CCCC | C4 THERAPEUTICS INC | $239.38M | -64.40% | -38.70% | -51.82% | -44.80% | 0.72 | 5.76 | 100.00% | -395.50% | -395.08% | ||
| TYRA | TYRA BIOSCIENCES INC | $1.21B | -35.80% | -33.60% | -39.05% | -47.60% | 0.08 | 17.71 | N/A | N/A | N/A | ||
| BLLN | BILLIONTOONE INC | $4.67B | N/A | N/A | N/A | N/A | -0.62 | 6.17 | N/A | N/A | N/A | ||
| OCUL | OCULAR THERAPEUTIX INC | $3.10B | -87.20% | -57.90% | -65.70% | -252.50% | 0.59 | 7.85 | 88.90% | -447.60% | -425.87% | ||
| CLFD | CLEARFIELD INC | $410.19M | -3.10% | -2.60% | -2.11% | -2.20% | 0.20 | 5.42 | 33.70% | -5.40% | -3.79% | ||
| TRVI | TREVI THERAPEUTICS INC | $1.64B | -31.20% | -29.30% | -24.11% | -50.10% | 0.05 | 21.93 | N/A | N/A | N/A | ||
| NEXN | NEXXEN INTERNATIONAL LTD | $198.73M | 7.90% | 5.10% | 10.31% | 72.20% | 0.59 | 1.25 | 85.00% | 10.50% | 13.43% | ||
| IMTX | IMMATICS NV | $1.22B | -23.30% | -19.10% | -26.21% | -40.90% | 0.24 | 7.36 | 100.00% | -136.70% | -141.11% | ||
| CARL | CARLSMED INC | $344.38M | N/A | N/A | N/A | N/A | 0.26 | 12.03 | N/A | N/A | N/A | ||
| TIGR | UP FINTECH HOLDING LTD | $1.64B | 21.10% | 1.90% | 23.20% | -6.70% | 10.47 | 1.09 | 64.20% | 31.40% | 39.01% | ||
| SLDB | SOLID BIOSCIENCES INC | $457.33M | -73.60% | -60.00% | -70.12% | -112.70% | 0.26 | 6.74 | N/A | N/A | N/A | ||
| OMDA | OMADA HEALTH INC | $874.41M | N/A | N/A | N/A | N/A | 0.32 | 3.64 | N/A | N/A | N/A | ||
| CGEM | CULLINAN THERAPEUTICS INC | $704.19M | -42.10% | -39.80% | -48.01% | -49.30% | 0.07 | 10.45 | N/A | N/A | N/A | ||
| ALEC | ALECTOR INC | $162.64M | -123.00% | -27.50% | -42.18% | -38.10% | 4.81 | 3.76 | 100.00% | -156.00% | -155.96% | ||
| CMPX | COMPASS THERAPEUTICS INC | $917.77M | -48.90% | -42.50% | -30.07% | -58.90% | 0.10 | 17.82 | N/A | N/A | N/A | ||
| CATX | PERSPECTIVE THERAPEUTICS INC | $198.48M | -39.10% | -33.20% | -39.26% | -49.80% | 0.22 | 8.66 | 100.00% | -9,841.90% | -10,014.70% | ||
| VTYX | VENTYX BIOSCIENCES INC | $584.43M | -48.10% | -43.90% | -53.25% | -50.70% | 0.11 | 17.86 | N/A | N/A | N/A | ||
| AIRG | AIRGAIN INC | $48.43M | -19.70% | -12.80% | -17.52% | -38.30% | 0.53 | 2.13 | 42.90% | -10.90% | -10.79% | ||
| EYPT | EYEPOINT PHARMACEUTICALS INC | $1.32B | -76.10% | -61.70% | -92.76% | -87.80% | 0.26 | 7.18 | 94.10% | -486.00% | -485.49% | ||
| OLMA | OLEMA PHARMACEUTICALS INC | $2.27B | -41.50% | -37.60% | -48.25% | -50.60% | 0.15 | 8.03 | N/A | N/A | N/A | ||
| LXEO | LEXEO THERAPEUTICS INC | $713.09M | -90.50% | -70.90% | -82.85% | -112.40% | 0.19 | 7.40 | N/A | N/A | N/A | ||
| T | AT&T INC | $174.26B | 20.90% | 5.50% | 9.02% | 11.20% | 2.68 | 1.01 | 59.70% | 17.80% | 26.78% | ||
| NRIX | NURIX THERAPEUTICS INC | $1.47B | -53.60% | -40.80% | -55.44% | -52.30% | 0.40 | 5.35 | 100.00% | -292.50% | -291.58% | ||
| NTSK | NETSKOPE INC | $8.15B | N/A | N/A | N/A | N/A | 10.36 | 2.33 | N/A | N/A | N/A |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.